Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia

Clinical trial NCT03827603 · UNKNOWN

Trial details

NCT number: NCT03827603
Sponsor: Eugene Nikitin
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

AIHA - Warm Autoimmune Hemolytic Anemia

Start date: 2017-02-21
Primary completion: 2019-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.